>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Newsroom

News of the Hour News Reader Market News Stock News Topics Social Sentiments Market TV Press Releases
Articles > Top gainers in Biotechnology and Gene Therapy - EDIT, TMO, AMGN, LLY, VRTX

Top gainers in Biotechnology and Gene Therapy - EDIT, TMO, AMGN, LLY, VRTX

By KlickAnalytics Data Insights  |   November 29, 2024 04:39PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.

Editas Medicine Inc (EDIT)
EDIT is trading UP for the last 1 days, and it at trading at $2.24 with volume of 1,235,596 and a one day change of $0.04 (1.82%). Editas Medicine Inc has a 52-week low of 2.14 and a 52-week high of $11.69. The business's 50-day moving average price is $2.97 and its 200 day moving average price is $4.21. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.01.

For more information on EDIT:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Thermo Fisher Scientific Inc. (TMO)
    TMO is trading UP for the last 2 days, and it at trading at $530.10 with volume of 1,699,177 and a one day change of $8.44 (1.62%). Thermo Fisher Scientific Inc. has a 52-week low of 480.57 and a 52-week high of $627.86. The business's 50-day moving average price is $556.45 and its 200 day moving average price is $579.34. The firm has a market cap of $213 million, a P/E ratio of 35.10, and a beta of 0.79.

    For more information on TMO:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • AMGEN Inc. (AMGN)
    AMGN is trading UP for the last 2 days, and it at trading at $283.00 with volume of 1,582,814 and a one day change of $2.93 (1.05%). AMGEN Inc. has a 52-week low of 257.80 and a 52-week high of $346.85. The business's 50-day moving average price is $310.01 and its 200 day moving average price is $317.81. The firm has a market cap of $170 million, a P/E ratio of 44.24, and a beta of 0.60.

    Top news headlines for AMGN

  • THOUSAND OAKS, Calif. , Nov. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 7th Annual Evercore HealthCONx Conference at 10:00 a.m.
  • Even though Amgen is weak below the 200-day line, there's still a way to profit. The post Wide Trading Range For Amgen Stock Makes This Option Shine appeared first on Investor's Business Daily.
  • Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
  • Shares of Amgen (AMGN 0.02%) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large pharma company's stock to fall, especially considering that the market rose nearly 3% in the same period. The clear culprit for the drop is, quite regrettably for shareholders, an unintentional disclosure of clinical trial information that the market found to be rather unappetizing.

    • For more information on AMGN:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Lilly(Eli) & Co (LLY)
    LLY is trading UP for the last 1 days, and it at trading at $795.36 with volume of 1,622,032 and a one day change of $7.17 (0.91%). Lilly(Eli) & Co has a 52-week low of 561.65 and a 52-week high of $972.53. The business's 50-day moving average price is $842.86 and its 200 day moving average price is $870.02. The firm has a market cap of $847 million, a P/E ratio of 112.43, and a beta of 0.43.

    Top news headlines for LLY

  • Lilly (LLY) reported earnings 30 days ago. What's next for the stock?
  • Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

    • For more information on LLY:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Vertex Pharmaceuticals, Inc. (VRTX)
    VRTX is trading UP for the last 1 days, and it at trading at $468.74 with volume of 482,189 and a one day change of $4.18 (0.90%). Vertex Pharmaceuticals, Inc. has a 52-week low of 346.29 and a 52-week high of $519.88. The business's 50-day moving average price is $475.85 and its 200 day moving average price is $474.03. The firm has a market cap of $122 million, a P/E ratio of 25.09, and a beta of 0.39.

    Top news headlines for VRTX

  • Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two stocks is more attractive to value investors?

    • For more information on VRTX:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

    Market News ×
    Loading news…